FR335M - New hydroxylated steroid drugs, in particular for the treatment of spasms of coronary origin. - Google Patents

New hydroxylated steroid drugs, in particular for the treatment of spasms of coronary origin.

Info

Publication number
FR335M
FR335M FR836270A FR836270A FR335M FR 335 M FR335 M FR 335M FR 836270 A FR836270 A FR 836270A FR 836270 A FR836270 A FR 836270A FR 335 M FR335 M FR 335M
Authority
FR
France
Prior art keywords
spasms
treatment
steroid drugs
hydroxylated steroid
coronary origin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR836270A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Francais de Chimiotherapie SA
Original Assignee
Laboratoires Francais de Chimiotherapie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Francais de Chimiotherapie SA filed Critical Laboratoires Francais de Chimiotherapie SA
Priority to FR836270A priority Critical patent/FR335M/en
Application granted granted Critical
Publication of FR335M publication Critical patent/FR335M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
FR836270A 1960-06-16 1960-08-19 New hydroxylated steroid drugs, in particular for the treatment of spasms of coronary origin. Active FR335M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR836270A FR335M (en) 1960-06-16 1960-08-19 New hydroxylated steroid drugs, in particular for the treatment of spasms of coronary origin.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR830184A FR1363865A (en) 1960-06-16 1960-06-16 New polyhydroxylated steroids and obtaining these compounds
FR836270A FR335M (en) 1960-06-16 1960-08-19 New hydroxylated steroid drugs, in particular for the treatment of spasms of coronary origin.

Publications (1)

Publication Number Publication Date
FR335M true FR335M (en) 1961-03-27

Family

ID=8733554

Family Applications (4)

Application Number Title Priority Date Filing Date
FR830184A Expired FR1363865A (en) 1960-06-16 1960-06-16 New polyhydroxylated steroids and obtaining these compounds
FR836270A Active FR335M (en) 1960-06-16 1960-08-19 New hydroxylated steroid drugs, in particular for the treatment of spasms of coronary origin.
FR836867A Active FR342M (en) 1960-06-16 1960-08-26 New tri-hydroxylated steroid drug, in particular for the treatment of spasms of coronary origin.
FR836866A Active FR341M (en) 1960-06-16 1960-08-26 New tetrahydroxylated steroid drug, in particular for the treatment of spasms of coronary origin.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR830184A Expired FR1363865A (en) 1960-06-16 1960-06-16 New polyhydroxylated steroids and obtaining these compounds

Family Applications After (2)

Application Number Title Priority Date Filing Date
FR836867A Active FR342M (en) 1960-06-16 1960-08-26 New tri-hydroxylated steroid drug, in particular for the treatment of spasms of coronary origin.
FR836866A Active FR341M (en) 1960-06-16 1960-08-26 New tetrahydroxylated steroid drug, in particular for the treatment of spasms of coronary origin.

Country Status (5)

Country Link
CH (3) CH413831A (en)
ES (3) ES268248A1 (en)
FR (4) FR1363865A (en)
GB (2) GB967080A (en)
SE (2) SE302454B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9649320B2 (en) 2008-05-28 2017-05-16 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9649320B2 (en) 2008-05-28 2017-05-16 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US10206933B2 (en) 2008-05-28 2019-02-19 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kB for treatment of disease
US10857161B2 (en) 2008-05-28 2020-12-08 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kB for treatment of disease
US11833159B2 (en) 2008-05-28 2023-12-05 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kB for treatment of disease
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11690853B2 (en) 2015-06-29 2023-07-04 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κβ for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions
US11471471B2 (en) 2019-03-07 2022-10-18 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions
US12201639B2 (en) 2019-03-07 2025-01-21 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Also Published As

Publication number Publication date
CH411863A (en) 1966-04-30
CH418331A (en) 1966-08-15
ES268247A1 (en) 1961-09-16
ES268248A1 (en) 1961-09-16
FR1363865A (en) 1964-06-19
FR342M (en) 1961-03-27
CH413831A (en) 1966-05-31
GB967078A (en) 1964-08-19
GB967080A (en) 1964-08-19
SE302454B (en) 1968-07-22
ES268249A1 (en) 1961-09-16
FR341M (en) 1961-03-27
SE301966B (en) 1968-07-01

Similar Documents

Publication Publication Date Title
FR1593M (en) Compositions for the treatment of acne.
FR335M (en) New hydroxylated steroid drugs, in particular for the treatment of spasms of coronary origin.
BE612141Q (en) New drugs in particular for the treatment of spasms of coronary origin.
FR2338M (en) New remedies intended in particular for the treatment of headaches of vascular origin.
FR334M (en) New dinitrated steroid drug, in particular for the treatment of spasms of coronary origin.
FR2969M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR2778M (en) New drugs, in particular for the treatment of spasms of coronary, vascular or visceral origin.
FR1764M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR133M (en) New dihydroxy drug, in particular for the treatment of spasms of coronary origin.
FR1141M (en) New drug in particular for the treatment of spasms of coronary origin.
FR1635M (en) New drug in particular for the treatment of spasms of coronary origin.
FR129M (en) New acetoxylated drug for the treatment of spasms of coronary origin.
FR55M (en) New drug, particularly for the treatment of coronary spasms
FR2810M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR2681M (en) New drug in particular for the treatment of spasms of coronary origin.
FR1946M (en) New drug in particular for the treatment of spasms of coronary origin.
FR3419M (en) New drugs, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1598M (en) New drug in particular for the treatment of spasms of vascular, coronary or visceral origin.
FR1886M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR2053M (en) New drug in particular for the treatment of spasms of coronary or vascular origin.
FR2374M (en) New drug in particular for the treatment of spasms of coronary or vascular origin.
BE616479A (en) Agents for the treatment of vascular spasms
BE598672A (en) Therapeutic composition for the treatment of hepatic disorders.
FR1407M (en) New drug, especially for the treatment of spasms of vascular origin.